Cover Image
市場調查報告書

美國的先進創傷管理用品市場未來展望

United States Advanced Wound Management Market Outlook to 2020

出版商 GlobalData 商品編碼 316768
出版日期 內容資訊 英文 236 Pages
訂單完成後即時交付
價格
Back to Top
美國的先進創傷管理用品市場未來展望 United States Advanced Wound Management Market Outlook to 2020
出版日期: 2014年10月15日 內容資訊: 英文 236 Pages
簡介

本報告提供美國的最新型的創傷管理用品市場現狀與未來發展預測相關分析,提供您整體市場規模(以金額·數量為準)的實際成果值·預測值,及個別產品的詳細趨勢,市場價格趨勢,市場佔有率(各流通管道·各企業),主要企業的概要與策略,最新的市場動靜(資本交易等)等調查。

第1章 目錄

第2章 簡介

  • 關於本報告內容
  • 先進創傷管理用品的分類
  • 分析對象定義

第3章 美國的先進創傷管理用品市場

  • 市場收益的實際成果值(以金額為準,過去9年份)
  • 市場收益的預測值(以金額為準,今後8年份)
  • 市場規模的實際成果值(以數量為準,過去9年份)
  • 市場規模的預測值(以數量為準,今後8年份)
    • 藻酸鹽:市場趨勢(以金額·數量為準,總計16年份)
    • 膠原蛋白:市場趨勢(以金額·數量為準,總計16年份)
    • 泡沫:市場趨勢(以金額·數量為準,總計16年份)
      • 抗菌性泡沫
      • 非抗菌性泡沫
    • 親水膠體敷料:市場趨勢(以金額·數量為準,總計16年份)
    • 親水性纖維敷料:市場趨勢(以金額·數量為準,總計16年份)
    • 水凝膠:市場趨勢(以金額·數量為準,總計16年份)
    • 半透膜:市場趨勢(以金額·數量為準,總計16年份)
      • 抗菌性半透膜
      • 非抗菌性半透膜
    • 超吸水劑:市場趨勢(以金額·數量為準,總計16年份)
    • 創傷接觸層:市場趨勢(以金額·數量為準,總計16年份)
  • 平均價格(總計16年份)
  • 各流通管道的市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第4章 主要企業概要

  • 3M Health Care Ltd
  • Smith & Nephew Plc
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • Coloplast A/S
  • Systagenix Wound Management Limited
  • Covidien plc
  • BSN medical GmbH
  • Derma Sciences, Inc.
  • Paul Hartmann AG
  • Hollister Incorporated
  • Laboratoires Urgo S.A.
  • ConvaTec Inc.

第5章 現在正在開發(開發平台上)的先進創傷管理用品

第6章 資本交易環境

  • 企業收購(全3件)
  • 股票上市(全4件)
  • 產業聯盟(全4件)
  • 私人股權(1件)
  • 風險企業投資(全6件)

第7章 近幾年趨勢

  • 企業通訊(全14件)
  • 財務相關資訊(全25件)
  • 政府·公益相關資訊(全4件)
  • 法規·規定趨勢(1件)
  • 其他重要的動向(全10件)
  • 產品資訊(全8件)
  • 策略·產業計畫資訊(全6件)

第8章 附錄

圖表一覽

目錄
Product Code: GDMECC0842DB

GlobalData's new report, "United States Advanced Wound Management Market Outlook to 2020", provides key market data on the United States Advanced Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Semi-Permeable Films (Antimicrobial Film Dressings (Antimicrobial Bordered and Non Bordered Film Dressings) and Non Antimicrobial Film Dressings (Non Antimicrobial Bordered and Non Bordered Film Dressings)), Foams (Antimicrobial Foam Dressings (Antimicrobial Bordered and Non Bordered Foam Dressings) and Non Antimicrobial Foam Dressings (Non Antimicrobial Bordered and Non Bordered Foam Dressings)), Hydrofibres (Antimicrobial and Non Antimicrobial Hydrofibre Dressings), Hydrocolloids (Antimicrobial and Non Antimicrobial Hydrocolloid Dressings), Hydrogels (Antimicrobial and Non Antimicrobial Hydrogel Dressings), Alginates (Antimicrobial and Non Antimicrobial Alginate Dressings), Collagens (Antimicrobial and Non Antimicrobial Collagen Dressings), Wound Contact Layers (Antimicrobial and Non Antimicrobial Wound Contact Layers) and Superabsorbents (Antimicrobial and Non Antimicrobial Superabsorbents).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Advanced Wound Management market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Advanced Wound Management market segments - Semi-Permeable Films, Foams, Hydrofibres, Hydrocolloids, Hydrogels, Alginates, Collagens, Wound Contact Layers and Superabsorbents.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Advanced Wound Management market.
  • Global corporate-level profiles of key companies operating within the United States Advanced Wound Management market.
  • Key players covered include 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Advanced Wound Management Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Advanced Wound Management Market, United States

  • 3.1. Advanced Wound Management Market, United States, Revenue ($m), 2005-2013
  • 3.2. Advanced Wound Management Market, United States, Revenue ($m), 2013-2020
    • 3.2.1. Alginates Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Collagens Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.3. Foams Market, United States, Revenue ($m), by Segment, 2005-2013
      • 3.2.3.1. Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013
      • 3.2.3.2. Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.4. Hydrocolloids Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.5. Hydrofibres Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.6. Hydrogels Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.7. Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2005-2013
      • 3.2.7.1. Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013
      • 3.2.7.2. Non Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 3.2.8. Superabsorbents Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.9. Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2005-2013
    • 3.2.10. Alginates Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.11. Collagens Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.12. Foams Market, United States, Revenue ($m), by Segment, 2013-2020
      • 3.2.12.1. Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020
      • 3.2.12.2. Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020
    • 3.2.13. Hydrocolloids Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.14. Hydrofibres Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.15. Hydrogels Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.16. Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2013-2020
      • 3.2.16.1. Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020
      • 3.2.16.2. Non Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020
    • 3.2.17. Superabsorbents Market, United States, Revenue ($m), by Segment, 2013-2020
    • 3.2.18. Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2013-2020
  • 3.3. Advanced Wound Management Market, United States, Volume (Units), 2005-2013
  • 3.4. Advanced Wound Management Market, United States, Volume (Units), 2013-2020
    • 3.4.1. Alginates Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.2. Collagens Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.3. Foams Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.3.1. Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013
      • 3.4.3.2. Non Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013
    • 3.4.4. Hydrocolloids Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.5. Hydrofibres Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.6. Hydrogels Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.7. Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2005-2013
      • 3.4.7.1. Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013
      • 3.4.7.2. Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013
    • 3.4.8. Superabsorbents Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.9. Wound Contact Layers Market, United States, Volume (Units), by Segment, 2005-2013
    • 3.4.10. Alginates Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.11. Collagens Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.12. Foams Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.12.1. Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020
      • 3.4.12.2. Non Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020
    • 3.4.13. Hydrocolloids Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.14. Hydrofibres Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.15. Hydrogels Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.16. Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2013-2020
      • 3.4.16.1. Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020
      • 3.4.16.2. Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020
    • 3.4.17. Superabsorbents Market, United States, Volume (Units), by Segment, 2013-2020
    • 3.4.18. Wound Contact Layers Market, United States, Volume (Units), by Segment, 2013-2020
  • 3.5. Advanced Wound Management Market, United States, Average Price ($), 2005-2020
  • 3.6. Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in United States, Advanced Wound Management Market

  • 4.1. 3M Health Care Ltd
    • 4.1.1. Company Overview
  • 4.2. Smith & Nephew Plc
    • 4.2.1. Company Overview
  • 4.3. Medline Industries, Inc.
    • 4.3.1. Company Overview
  • 4.4. Molnlycke Health Care AB
    • 4.4.1. Company Overview
  • 4.5. Coloplast A/S
    • 4.5.1. Company Overview
  • 4.6. Systagenix Wound Management Limited
    • 4.6.1. Company Overview
  • 4.7. Covidien plc
    • 4.7.1. Company Overview
  • 4.8. BSN medical GmbH
    • 4.8.1. Company Overview
  • 4.9. Derma Sciences, Inc.
    • 4.9.1. Company Overview
  • 4.10. Paul Hartmann AG
    • 4.10.1. Company Overview
  • 4.11. Hollister Incorporated
    • 4.11.1. Company Overview
  • 4.12. Laboratoires Urgo S.A.
    • 4.12.1. Company Overview
  • 4.13. ConvaTec Inc.
    • 4.13.1. Company Overview

5. Advanced Wound Management Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Avista Capital Partners and Nordic Capital May Sell ConvaTec
    • 6.1.2. Medtronic May Acquire Smith & Nephew
    • 6.1.3. Smith & Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million
  • 6.2. Equity Offerings
    • 6.2.1. Dara BioSciences Raises USD12.5 Million in Public Offering of Units
    • 6.2.2. Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million
    • 6.2.3. Sanuwave Health Completes Private Placement Of Shares For US$10 Million
    • 6.2.4. Dara BioSciences Announces Private Placement Of Shares For US$6 Million
    • 6.2.5. Sanuwave Health Completes Private Placement Of Shares For US$0.3 Million
    • 6.2.6. Sanuwave Health Completes Private Placement Of Shares For US$0.2 Million
    • 6.2.7. Derma Sciences Completes Public Offering Of Shares For US$86.3 Million
    • 6.2.8. Sanuwave Health Completes Private Placement Of Shares For US$0.1 Million
  • 6.3. Partnerships
    • 6.3.1. Medline Industries Enters Into Licensing Agreement With Quick-Med For Stay-Fresh Antimicrobial Technology
    • 6.3.2. Sanuwave Health And Wirthlin Form Joint Venture
    • 6.3.3. Sarasota Medical Enters Into Licensing Agreement With Quick-Med Technologies For Stay-Fresh Antimicrobial Technology
    • 6.3.4. PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb
  • 6.4. Private Equity
    • 6.4.1. Private Equity Owners Evaluate Options For Biomet Exit
  • 6.5. Venture Financing
    • 6.5.1. PolyRemedy Raises USD5 Million in Venture Financing
    • 6.5.2. St. Teresa Medical Raises USD1.13 Million in Venture Financing
    • 6.5.3. Chitogen Raises US$0.1 Million In Venture Financing
    • 6.5.4. St. Teresa Medical Raises USD0.7 Million in Venture Financing
    • 6.5.5. Vomaris Innovations Raises US$5 Million In Venture Financing
    • 6.5.6. Soluble Systems Raises US$3.5 Million In Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Sep 29, 2014: AHS Leader Wright Lassiter New President of Henry Ford Health System
    • 7.1.2. Jul 22, 2014: ConvaTec Names Nigel Clerkin Chief Financial Officer
    • 7.1.3. Jul 09, 2014: Spiracur Appoints Chris Fashek as Its New President and CEO
    • 7.1.4. Jun 17, 2014: DARA BioSciences Announces Leadership Transition
    • 7.1.5. Apr 21, 2014: SANUWAVE Health Announces Executive Changes
    • 7.1.6. Mar 25, 2014: Chesapeake IRB Acquires Goodwyn IRB
    • 7.1.7. Mar 06, 2014: Henry Ford West Bloomfield Hospital Names Chief Medical Officer
    • 7.1.8. Feb 25, 2014: DARA BioSciences Regains Compliance With NASDAQ Bid Price Requirement
    • 7.1.9. Jan 27, 2014: John Cannon Named CFO of ConvaTec
    • 7.1.10. Dec 09, 2013: ACell Nearly Doubles Board of Directors with Addition of Three Members
    • 7.1.11. Nov 12, 2013: NASDAQ Grants DARA BioSciences 180-Day Extension to Regain Compliance With Bid Price Requirement
    • 7.1.12. Nov 05, 2013: ImmunoGen Initiates Phase I Testing of Its EGFR-Targeting ADC, IMGN289
    • 7.1.13. Oct 28, 2013: DARA BioSciences Announces Sales Force Expansion and Agreement With Mission Pharmacal in the Oncology Market
    • 7.1.14. Oct 28, 2013: President and CEO Announced for HF West Bloomfield Hospital
  • 7.2. Financial Announcements
    • 7.2.1. Aug 15, 2014: ULURU Reports Second Quarter 2014 Financial Results
    • 7.2.2. Aug 12, 2014: DARA BioSciences Announces Second Quarter 2014 Results
    • 7.2.3. Aug 07, 2014: Derma Sciences Reports Second Quarter Financial Results
    • 7.2.4. Aug 06, 2014: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update
    • 7.2.5. Jun 17, 2014: OrthAlign Announces US FDA Clearance for ORTHALIGN PLUS, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery: Cup Placement, Leg Length, and Offset
    • 7.2.6. May 16, 2014: ULURU Inc. Reports First Quarter 2014 Financial Results
    • 7.2.7. May 13, 2014: SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update
    • 7.2.8. May 12, 2014: DARA BioSciences Announces First Quarter 2014 Results
    • 7.2.9. May 08, 2014: Derma Sciences Reports First Quarter Financial Results
    • 7.2.10. May 06, 2014: ConvaTec Reports Strong Financial Results for Fiscal Year 2013
    • 7.2.11. Apr 10, 2014: Abbott Completes Enrollment of Absorb Randomized Clinical Trials in the United States, Japan and China
    • 7.2.12. Apr 01, 2014: ULURU Reports Financial Results For Fourth Quarter And Year Ending December 31, 2013
    • 7.2.13. Mar 14, 2014: Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products
    • 7.2.14. Feb 04, 2014: DARA Reports 2013 Fourth Quarter and Full Year Financial Results and Commercial Business Update
    • 7.2.15. Jan 22, 2014: BIOTRONIK Enrolls First Patients in Expansion of ProMRI Clinical Trial
    • 7.2.16. Jan 16, 2014: Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance
    • 7.2.17. Nov 15, 2013: ULURU Reports Third Quarter 2013 Financial Results
    • 7.2.18. Nov 14, 2013: DARA Reports Third Quarter 2013 Financial Results and Highlights Commercial Momentum on Synergistic Oncology Supportive Care Product Portfolio
    • 7.2.19. Nov 14, 2013: ConvaTec announces 2013 third quarter earnings call
    • 7.2.20. Nov 13, 2013: Derma Sciences Reports Third Quarter Financial Results
    • 7.2.21. Nov 12, 2013: ULURU Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
    • 7.2.22. Nov 12, 2013: DARA BioSciences to Announce Third Quarter 2013 Financial Results and Corporate Business Update on November 14, 2013
    • 7.2.23. Nov 07, 2013: SANUWAVE to Hold Third Quarter Financial Results Conference Call on Tuesday, November 12
    • 7.2.24. Nov 06, 2013: Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 13th
    • 7.2.25. Oct 31, 2013: Isolite Systems Launches Isovac Dental Isolation Adapter
  • 7.3. Government and Public Interest
    • 7.3.1. Dec 09, 2013: Henry Ford Hospital Performs Minimally Invasive Laser Brain Surgeries
    • 7.3.2. Dec 04, 2013: Derma Sciences to Present at the Oppenheimer & Co. Inc. 24th Annual Healthcare Conference
    • 7.3.3. Nov 25, 2013: Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference
    • 7.3.4. Nov 12, 2013: Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum
  • 7.4. Legal And Regulatory
    • 7.4.1. Jan 09, 2014: CareFusion Issues Statement About Previously Disclosed Government Settlement
  • 7.5. Other Significant Developments
    • 7.5.1. Jul 24, 2014: Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing
    • 7.5.2. Jul 22, 2014: Henry Ford Health System named finalist for AHA's inaugural Equity of Care Award
    • 7.5.3. Mar 25, 2014: Henry Ford Joins Largest Health Information Exchange in Michigan
    • 7.5.4. Mar 24, 2014: HemCon Medical Technologies Revenue Growth Surges in Japan
    • 7.5.5. Mar 12, 2014: Henry Ford Hospital Heart Study Wins Award
    • 7.5.6. Feb 26, 2014: ULURU Provides Business Update
    • 7.5.7. Feb 04, 2014: JFCI Awarded 3-Year Accreditation from American College of Surgeons
    • 7.5.8. Jan 21, 2014: Personal Genome Enters Into Licensing Agreement With Johns Hopkins University
    • 7.5.9. Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases
    • 7.5.10. Oct 28, 2013: MRIGlobal Wins Subcontract to Evaluate New Treatment for Wound Care
  • 7.6. Product News
    • 7.6.1. Jun 03, 2014: DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Effect Management
    • 7.6.2. Feb 25, 2014: Study Finds That Consumers Prefer Regenica Overnight Repair To SkinMedica TNS Essential Serum
    • 7.6.3. Feb 17, 2014: Clinical Trial to Study Genetics of Keloid Scars
    • 7.6.4. Jan 16, 2014: ConvaTec Announces New Continuing Education Courses in Wound and Skin Care
    • 7.6.5. Jan 14, 2014: ConvaTec Launches Ostomysecrets in Europe
    • 7.6.6. Dec 16, 2013: Henry Ford Implants New Defibrillator for Sudden Cardiac Arrest
    • 7.6.7. Nov 18, 2013: BioLargo Granted Additional Patent as It Lands Second Order From US Government
    • 7.6.8. Nov 13, 2013: CareFusion Updates Labeling For ChloraPrep Products
  • 7.7. Strategy And Business Planning
    • 7.7.1. Jun 23, 2014: Neuro Resource Group's Hospital Presence Continues to Expand
    • 7.7.2. Feb 26, 2014: Henry Ford Hospital Opens Pigmented Lesions Clinic
    • 7.7.3. Feb 11, 2014: ConvaTec To Close Skillman Office In New Jersey
    • 7.7.4. Jan 24, 2014: Henry Ford Innovations Joins Carnegie Mellon Center
    • 7.7.5. Jan 22, 2014: Henry Ford Innovations Establishes William Davidson Center
    • 7.7.6. Oct 25, 2013: ACell Expands Indiana Manufacturing Facility to Support Growth

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Alginates Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Collagens Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 5: Foams Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 6: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 7: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 8: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 9: Hydrofibres Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 10: Hydrogels Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 11: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 12: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 13: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 14: Superabsorbents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 15: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 16: Alginates Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 17: Collagens Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 18: Foams Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 19: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 20: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 21: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 22: Hydrofibres Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 23: Hydrogels Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 24: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 25: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 26: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 27: Superabsorbents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 28: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 29: Advanced Wound Management Market, United States, Volume (Units), Historic, 2005-2013
  • Table 30: Advanced Wound Management Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 31: Alginates Market, United States, Volume (Units), Historic, 2005-2013
  • Table 32: Collagens Market, United States, Volume (Units), Historic, 2005-2013
  • Table 33: Foams Market, United States, Volume (Units), Historic, 2005-2013
  • Table 34: Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 35: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Table 36: Hydrocolloids Market, United States, Volume (Units), Historic, 2005-2013
  • Table 37: Hydrofibres Market, United States, Volume (Units), Historic, 2005-2013
  • Table 38: Hydrogels Market, United States, Volume (Units), Historic, 2005-2013
  • Table 39: Semi-Permeable Films Market, United States, Volume (Units), Historic, 2005-2013
  • Table 40: Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Table 41: Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013
  • Table 42: Superabsorbents Market, United States, Volume (Units), Historic, 2005-2013
  • Table 43: Wound Contact Layers Market, United States, Volume (Units), Historic, 2005-2013
  • Table 44: Alginates Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 45: Collagens Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 46: Foams Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 47: Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 48: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 49: Hydrocolloids Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 50: Hydrofibres Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 51: Hydrogels Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 52: Semi-Permeable Films Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 53: Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 54: Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, Forecast, 2013-2020
  • Table 55: Superabsorbents Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 56: Wound Contact Layers Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 57: Advanced Wound Management Market, United States, Average Price ($), Historic, 2005-2013
  • Table 58: Advanced Wound Management Market, United States, Average Price ($), Forecast, 2013-2020
  • Table 59: Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 60: Advanced Wound Management Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 61: Advanced Wound Management Market Pipeline Products
  • Table 62: Avista Capital Partners and Nordic Capital May Sell ConvaTec
  • Table 63: Medtronic May Acquire Smith & Nephew
  • Table 64: Smith & Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million
  • Table 65: Dara BioSciences Raises USD12.5 Million in Public Offering of Units
  • Table 66: Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million
  • Table 67: Sanuwave Health Completes Private Placement Of Shares For US$10 Million
  • Table 68: Dara BioSciences Announces Private Placement Of Shares For US$6 Million
  • Table 69: Sanuwave Health Completes Private Placement Of Shares For US$0.3 Million
  • Table 70: Sanuwave Health Completes Private Placement Of Shares For US$0.2 Million
  • Table 71: Derma Sciences Completes Public Offering Of Shares For US$86.3 Million
  • Table 72: Sanuwave Health Completes Private Placement Of Shares For US$0.1 Million
  • Table 73: Medline Industries Enters Into Licensing Agreement With Quick-Med For Stay-Fresh Antimicrobial Technology
  • Table 74: Sanuwave Health And Wirthlin Form Joint Venture
  • Table 75: Sarasota Medical Enters Into Licensing Agreement With Quick-Med Technologies For Stay-Fresh Antimicrobial Technology
  • Table 76: PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb
  • Table 77: Private Equity Owners Evaluate Options For Biomet Exit
  • Table 78: PolyRemedy Raises USD5 Million in Venture Financing
  • Table 79: St. Teresa Medical Raises USD1.13 Million in Venture Financing
  • Table 80: Chitogen Raises US$0.1 Million In Venture Financing
  • Table 81: St. Teresa Medical Raises USD0.7 Million in Venture Financing
  • Table 82: Vomaris Innovations Raises US$5 Million In Venture Financing
  • Table 83: Soluble Systems Raises US$3.5 Million In Venture Financing
  • Table 84: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Alginates Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Collagens Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 5: Foams Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 6: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 7: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 8: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 9: Hydrofibres Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 10: Hydrogels Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 11: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 12: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 13: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 14: Superabsorbents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 15: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 16: Alginates Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 17: Collagens Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 18: Foams Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 19: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 20: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 21: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 22: Hydrofibres Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 23: Hydrogels Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 24: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 25: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 26: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 27: Superabsorbents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 28: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 29: Advanced Wound Management Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 30: Advanced Wound Management Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 31: Alginates Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 32: Collagens Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 33: Foams Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 34: Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 35: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 36: Hydrocolloids Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 37: Hydrofibres Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 38: Hydrogels Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 39: Semi-Permeable Films Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 40: Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 41: Non Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 42: Superabsorbents Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 43: Wound Contact Layers Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 44: Alginates Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 45: Collagens Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 46: Foams Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 47: Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 48: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 49: Hydrocolloids Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 50: Hydrofibres Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 51: Hydrogels Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 52: Semi-Permeable Films Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 53: Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 54: Non Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 55: Superabsorbents Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 56: Wound Contact Layers Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 57: Advanced Wound Management Market, United States, Company Share (%), 2013
  • Figure 58: GlobalData Epidemiology-Based Forecasting Model
  • Figure 59: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 60: Primary Interviews by Participant Type (%)
Back to Top